Gayle Furgurson Wellborn - 12 Dec 2025 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Michael Newton, Attorney-in-Fact
Issuer symbol
HQY
Transactions as of
12 Dec 2025
Net transactions value
-$206,602
Form type
4
Filing time
16 Dec 2025, 15:44:01 UTC
Previous filing
30 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wellborn Gayle Furgurson Director C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER /s/ Michael Newton, Attorney-in-Fact 16 Dec 2025 0001712960

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Options Exercise $218,729 +4,339 +22% $50.41 24,072 12 Dec 2025 Direct
transaction HQY Common Stock Sale $425,331 -4,339 -18% $98.03 19,733 12 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HQY Stock Options (right to buy) Options Exercise $0 -4,339 -100% $0.000000 0 12 Dec 2025 Common Stock 4,339 $50.41 Direct F2
holding HQY Stock Option (right to buy) 2,439 12 Dec 2025 Common Stock 2,439 $47.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.87 to $98.20 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
F2 The option is immediately exercisable.

Remarks:

The Power of Attorney given by Ms. Wellborn was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023, as an exhibit to a statement on Form 4 filed by Ms. Wellborn with respect to HealthEquity, Inc. and is hereby incorporated by reference.